Mydecine Innovations Group Inc. announced that it has entered into a subscription agreement for private placement of 326,666 common shares at a price of CAD 0.75 per share for gross proceeds of CAD 244,999.50 with a third-party investor on August 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.007635 USD | +0.46% | -28.30% | -48.99% |
May. 01 | Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding | CI |
Feb. 23 | Mydecine Innovations Closes Partial Debt Settlement | MT |
1st Jan change | Capi. | |
---|---|---|
-48.99% | 472K | |
+40.80% | 53.67B | |
-8.05% | 38.76B | |
+35.79% | 38.86B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- MYCOF Stock
- News Mydecine Innovations Group Inc.
- Mydecine Innovations Group Inc. announced that it expects to receive CAD 0.245 million in funding